Overview

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors — by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Summarize the evolving therapeutic strategies in the treatment of solid tumor malignancies.
• Provide an update of new molecular and targeted treatments being developed for these diseases.
• Discuss the rationale for new targeted diagnostic and therapeutic strategies for lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors.
• Review the role and timing of diagnostic tests, molecular profiling and potential combinations of targeted therapy treatment options.

Target Audience

This educational program is directed toward oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, pharmacists, medical students, residents and fellows in training, research staff and other allied healthcare members interested in the treatment of patients with solid tumor malignancies.

Accreditation

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

For more information please visit the official event page.